Three months ended September 30, Nine months ended September 30, 2022 2021 2022 2021 Net sales $ 8,619 $ 8,942 $ 26,150 $ 26,743 Operating expenses Cost of sales 4,728 4,853 14,647 14,097 Selling, general and administrative expenses 1,998 1,819 6,903 5,373 Research, development and related expenses 461 482 1,417 1,520 Gain on business divestitures (2,724) — (2,724) — Total operating expenses 4,463 7,154 20,243 20,990 Operating income 4,156 1,788 5,907 5,753 Other expense (income), net 24 31 112 113 Income before income taxes 4,132 1,757 5,795 5,640 Provision for income taxes 271 324 550 1,058 Income of consolidated group 3,861 1,433 5,245 4,582 Income (loss) from unconsolidated subsidiaries, net of taxes 2 4 3 7 Net income including noncontrolling interest 3,863 1,437 5,248 4,589 Less: Net income (loss) attributable to noncontrolling interest 4 3 12 7 Net income attributable to 3M $ 3,859 $ 1,434 $ 5,236 $ 4,582 Weighted average 3M common shares outstanding – basic 568.8 579.6 570.7 580.3 Earnings per share attributable to 3M common shareholders – basic $ 6.79 $ 2.47 $ 9.18 $ 7.90 Weighted average 3M common shares outstanding – diluted 570.0 586.3 572.6 587.1 Earnings per share attributable to 3M common shareholders – diluted $ 6.77 $ 2.45 $ 9.15 $ 7.81 3M Company and Subsidiaries CONSOLIDATED STATEMENT OF INCOME (Millions, except per-share amounts) (Unaudited) -- 1 of 15 -- September 30, 2022 December 31, 2021 ASSETS Current assets Cash and cash equivalents $ 3,404 $ 4,564 Marketable securities – current 185 201 Accounts receivable – net 4,722 4,660 Inventories 5,615 4,985 Prepaids 467 654 Other current assets 502 339 Total current assets 14,895 15,403 Property, plant and equipment – net 9,196 9,429 Operating lease right of use assets 801 858 Goodwill and intangible assets – net 17,484 18,774 Other assets 3,800 2,608 Total assets $ 46,176 $ 47,072 LIABILITIES AND EQUITY Current liabilities Short-term borrowings and current portion of long-term debt $ 1,856 $ 1,307 Accounts payable 3,063 2,994 Accrued payroll 717 1,020 Accrued income taxes 270 260 Operating lease liabilities – current 241 263 Other current liabilities 3,396 3,191 Total current liabilities 9,543 9,035 Long-term debt 13,849 16,056 Other liabilities 8,628 6,864 Total liabilities 32,020 31,955 Total equity 14,156 15,117 Shares outstanding September 30, 2022: 552,742,915 December 31, 2021: 571,845,478 Total liabilities and equity $ 46,176 $ 47,072 3M Company and Subsidiaries CONDENSED CONSOLIDATED BALANCE SHEET (Dollars in millions) (Unaudited) -- 2 of 15 -- Nine months ended September 30, 2022 2021 NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES $ 3,669 $ 5,449 Cash flows from investing activities: Purchases of property, plant and equipment (1,243) (1,047) Purchases and proceeds from sale or maturities of marketable securities and investments – net 28 (447) Proceeds from sale of businesses, net of cash sold 13 — Cash payment from Food Safety business split-off, net of divested cash 478 — Other investing activities 66 62 NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES (658) (1,432) Cash flows from financing activities: Change in debt (838) (445) Purchases of treasury stock (928) (1,261) Proceeds from issuances of treasury stock pursuant to stock option and benefit plans 310 566 Dividends paid to shareholders (2,550) (2,572) Other financing activities (29) (21) NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES (4,035) (3,733) Effect of exchange rate changes on cash and cash equivalents (136) (40) Net increase (decrease) in cash and cash equivalents (1,160) 244 Cash and cash equivalents at beginning of year 4,564 4,634 Cash and cash equivalents at end of period $ 3,404 $ 4,878 3M Company and Subsidiaries CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS (Dollars in millions) (Unaudited) -- 3 of 15 -- Three months ended September 30, 2021 GAAP $ 562 18.7 % $ 1,788 20.0 % $ 1,757 $ 324 18.4 % $ 1,434 $ 2.45 Adjustments for special items: Net costs for significant litigation 60 97 97 18 79 0.13 Three months ended September 30, 2021 adjusted amounts (non-GAAP measures) (a) $ 622 20.7 % $ 1,885 21.1 % $ 1,854 $ 342 18.5 % $ 1,513 $ 2.58 Three months ended September 30, 2022 GAAP $ 652 22.5 % $ 4,156 48.2 % $ 4,132 $ 271 6.6 % $ 3,859 $ 6.77 177 % Adjustments for special items: Net costs for significant litigation 21 267 267 57 210 0.37 Divestiture costs — 6 6 2 4 0.01 Gain on business divestitures — (2,724) (2,724) (39) (2,685) (4.71) Divestiture-related restructuring actions — 41 41 9 32 0.05 Russia exit charges — 109 109 (2) 111 0.20 Total special items 21 (2,301) (2,301) 27 (2,328) (4.08) Three months ended September 30, 2022 adjusted amounts (non-GAAP measures) (a) 673 23.2 % $ 1,855 21.5 % $ 1,831 $ 298 16.2 % $ 1,531 $ 2.69 4 % Nine months ended September 30, 2021 GAAP 1,976 21.6 % $ 5,753 21.5 % $ 5,640 $ 1,058 18.8 % $ 4,582 $ 7.81 Adjustments for special items: Net costs for significant litigation 177 $ 359 $ 359 $ 80 $ 279 $ 0.47 Nine months ended September 30, 2021 adjusted amounts (non-GAAP measures) (a) 2,153 23.6 % $ 6,112 22.9 % $ 5,999 $ 1,138 19.0 % $ 4,861 $ 8.28 Nine months ended September 30, 2022 GAAP 581 6.6 % $ 5,907 22.6 % $ 5,795 $ 550 9.5 % $ 5,236 $ 9.15 17 % Adjustments for special items: Net costs for significant litigation 1,421 2,233 2,233 456 1,777 3.10 Divestiture costs — 6 6 2 4 0.01 Gain on business divestitures — (2,724) (2,724) (39) (2,685) (4.69) Divestiture-related restructuring actions — 41 41 9 32 0.06 Russia exit charges — 109 109 (2) 111 0.19 Total special items 1,421 (335) (335) 426 (761) (1.33) Nine months ended September 30, 2022 adjusted amounts (non-GAAP measures) (a) 2,002 22.6 % $ 5,572 21.3 % $ 5,460 $ 976 17.9 % $ 4,475 $ 7.82 (6) % Operating Income (Loss) Net Income Attrib- utable to 3M Earnings per diluted share percent change (Dollars in millions, except per share amounts) Safety and Industrial Safety and Industrial Margin Total Company Total Company Margin Income Before Taxes Provision for Income Taxes Effective Tax Rate Earnings per Diluted Share 3M Company and Subsidiaries SUPPLEMENTAL FINANCIAL INFORMATION NON-GAAP MEASURES (Unaudited) -- 4 of 15 -- (Dollars in millions, except per share amounts) Full Year 2022 Forecast Earnings per share 2022 adjusted earnings per share amounts (non-GAAP measures) *(a) $10.10 to $10.35 * 3M cannot, without unreasonable effort, forecast certain items required to develop meaningful comparable GAAP financial measures and, therefore, does not provide them on a forward-looking basis reflecting these items. These include, but are not limited to, special items such as net costs for significant litigation, projected divestiture gains, divestiture costs, and divestiture-related restructuring. This is due to limitations in predicting with reasonable certainty the timing and ultimate outcome of significant litigation, certain conditions outside of 3M’s control regarding divestitures, the meaningful amount and timing of costs involved over the duration of an announced segment-sized divestiture, and numerous other conditions outside of 3M’s control. 3M believes these limitations would result in a range of projected values so broad as to not be meaningful to investors. For these reasons, 3M believes that the probable significance of such information is low. Additionally, for similar reasons, 3M does not include the impact of potentially-divested businesses on expected operations in the forecasted outlook guidance it provides until close of a transaction. Information with respect to special items for applicable historical periods is included herein. __________________________ (a) In addition to reporting financial results in accordance with U.S. GAAP, 3M also provides non-GAAP measures that adjust for the impacts of special items. Special items for the periods presented include the items described in the section entitled “Description of Special Items”. Operating income (loss), segment operating income (loss), income before taxes, net income, earnings per share, and the effective tax rate are all measures for which 3M provides the reported GAAP measure and a measure adjusted for special items. The adjusted measures are not in accordance with, nor are they a substitute for, GAAP measures. While the Company includes certain items in its measure of segment operating performance, it also considers these non-GAAP measures in evaluating and managing its operations. The Company believes that discussion of results adjusted for special items is useful to investors in understanding underlying business performance, while also providing additional transparency to the special items. Special items impacting operating income (loss) are reflected in Corporate and Unallocated, except as described with respect to net costs for significant litigation in the “Description of Special Items” section. The determination of these items may not be comparable to similarly titled measures used by other companies. In the first quarter of 2022, the Company changed the extent of matters and charges/benefits it includes within special items with respect to net costs for significant litigation. Previously, 3M included net costs, when significant, associated with changes in accrued liabilities related to respirator mask/asbestos litigation and PFAS-related other environmental matters, along with the associated tax impacts. The non-GAAP measure changes involved including net costs for litigation related to 3M's Combat Arms Earplugs, expanding net costs to include external legal fees and insurance recoveries associated with the applicable matters in addition to changes in accrued liabilities, and to include all such net costs for the applicable matters, not just when considered significant. The information provided herein reflects the impacts of these changes for all periods presented. 3M Company and Subsidiaries SUPPLEMENTAL FINANCIAL INFORMATION NON-GAAP MEASURES (CONTINUED) (Unaudited) -- 5 of 15 -- Three months ended September 30, Nine months ended September 30, Major GAAP Cash Flow Categories (dollars in millions) 2022 2021 2022 2021 Net cash provided by (used in) operating activities $ 1,531 $ 1,874 $ 3,669 $ 5,449 Net cash provided by (used in) investing activities 156 (389) (658) (1,432) Net cash provided by (used in) financing activities (933) (1,299) (4,035) (3,733) Major GAAP Cash Flow Categories (dollars in billions) Full-Year 2022 Forecast Net cash provided by (used in) operating activities* $6.8 to $7.4 Purchase of property, plant and equipment ($1.75 to $1.85) Free cash flow $4.9 to $5.6 Adjustments for special items* — Adjusted free cash flow(b) $4.9 to $5.6 Net income attributable to 3M* $5.8 to $5.9 Adjustments for special items* — Adjusted net income attributable to 3M*(a) $5.8 to $5.9 Adjusted free cash flow conversion*(b) 85% to 95% * 3M cannot, without unreasonable effort, forecast certain items required to develop meaningful comparable GAAP financial measures and, therefore, does not provide them on a forward-looking basis reflecting these items. These include, but are not limited to, special items such as net costs for significant litigation, projected divestiture gains, divestiture costs, and divestiture-related restructuring. This is due to limitations in predicting with reasonable certainty the timing and ultimate outcome of significant litigation, certain conditions outside of 3M’s control regarding divestitures, the meaningful amount and timing of costs involved over the duration of an announced segment-sized divestiture, and numerous other conditions outside of 3M’s control. 3M believes these limitations would result in a range of projected values so broad as to not be meaningful to investors. For these reasons, 3M believes that the probable significance of such information is low. Additionally, for similar reasons, 3M does not include the impact of potentially-divested businesses on expected operations in the forecasted outlook guidance it provides until close of a transaction. Information with respect to special items for applicable historical periods is included herein. 3M Company and Subsidiaries SUPPLEMENTAL FINANCIAL INFORMATION NON-GAAP MEASURES (CONTINUED) (Unaudited) -- 6 of 15 -- Three months ended September 30, Nine months ended September 30, Adjusted Free Cash Flow (non-GAAP measure) (dollars in millions) 2022 2021 2022 2021 Net cash provided by (used in) operating activities $ 1,531 $ 1,874 $ 3,669 $ 5,449 Purchases of property, plant and equipment (435) (343) (1,243) (1,047) Free cash flow 1,096 1,531 2,426 4,402 Adjustments for special items: Net costs for significant litigation after-tax payment impacts 250 84 538 204 TCJA transition tax payment — — 68 77 Divestiture-related restructuring after-tax payment impacts 4 1 4 5 Divestiture costs after-tax payment impacts 2 — 2 — Russia exit charges after-tax payment impacts 2 — 2 — Total adjustments for special items 258 85 614 286 Adjusted free cash flow (b) 1,354 1,616 3,040 4,688 Net income attributable to 3M $ 3,859 $ 1,434 $ 5,236 $ 4,582 Adjustments for special items: Net costs for significant litigation 210 79 1,777 279 Divestiture costs 4 — 4 — Gain on business divestitures (2,685) — (2,685) — Divestiture-related restructuring actions 32 — 32 — Russia exit charges 111 — 111 — Total special items (2,328) 79 (761) 279 Adjusted net income attributable to 3M (a) $ 1,531 $ 1,513 $ 4,475 $ 4,861 Adjusted free cash flow conversion (b) 88 % 107 % 68 % 96 % ______________________________________ (b) Adjusted free cash flow and adjusted free cash flow conversion are not defined under U.S. GAAP. Therefore, they should not be considered a substitute for income or cash flow data prepared in accordance with U.S. GAAP and may not be comparable to similarly titled measures used by other companies. The Company defines adjusted free cash flow as net cash provided by operating activities, adjusted for special items, less purchases of property, plant and equipment. Cash payments associated with special items in the determination of adjusted free cash flow are reflected net of applicable tax using the U.S. statutory corporate tax rate during the period of payment. It should not be inferred that the entire adjusted free cash flow amount is available for discretionary expenditures. The Company defines adjusted free cash flow conversion as adjusted free cash flow divided by net income attributable to 3M, adjusted for special items. Special items for the periods presented include the items described in section entitled “Description of Special Items”. The Company believes adjusted free cash flow and adjusted free cash flow conversion are meaningful to investors as they are useful measures of performance and the Company uses these measures as an indication of the strength of the company and its ability to generate cash. 3M Company and Subsidiaries SUPPLEMENTAL FINANCIAL INFORMATION NON-GAAP MEASURES (CONTINUED) (Unaudited) -- 7 of 15 -- Adjusted EBITDA (non-GAAP measure) (c) Adjusted EBITDA Margin (non-GAAP measure) (c) Three months ended September 30, Nine months ended September 30, Three months ended September 30, Nine months ended September 30, (Dollars in millions) 2022 2021 2022 2021 2022 2021 2022 2021 Safety and Industrial $ 810 $ 771 $ 2,427 $ 2,593 28.0 % 25.7 % 27.4 % 28.4 % Transportation and Electronics 573 541 1,748 1,812 25.7 % 23.3 % 25.5 % 25.6 % Health Care 603 668 1,855 1,999 29.1 % 30.7 % 29.1 % 31.2 % Consumer 336 345 881 975 23.8 % 24.1 % 21.7 % 23.7 % Corporate and Unallocated (17) 36 32 141 Total Company $ 2,305 $ 2,361 $ 6,943 $ 7,520 26.7 % 26.4 % 26.6 % 28.1 % Three months ended September 30, Nine months ended September 30, Adjusted EBITDA (non-GAAP measure) (dollars in millions) 2022 2021 2022 2021 Net sales $ 8,619 $ 8,942 $ 26,150 $ 26,743 Net income attributable to 3M 3,859 1,434 5,236 4,582 Add/(subtract): Net income/(loss) attributable to noncontrolling interest 4 3 12 7 (Income)/loss from unconsolidated subsidiaries, net of taxes (2) (4) (3) (7) Provision for income taxes 271 324 550 1,058 Other expense/(income): Interest (Income)/expense 89 111 311 352 Pension & OPEB non-service cost (benefit) (65) (80) (199) (239) Depreciation and amortization expense 450 476 1,371 1,408 Adjustments for special items: Net costs for significant litigation 267 97 2,233 359 Divestiture costs 6 — 6 — Gain on business divestitures (2,724) — (2,724) — Divestiture-related restructuring actions 41 — 41 — Russia exit charges 109 — 109 — Total special items (2,301) 97 (335) 359 Adjusted EBITDA (c) $ 2,305 $ 2,361 $ 6,943 $ 7,520 Adjusted EBITDA margin (c) 26.7 % 26.4 % 26.6 % 28.1 % 3M Company and Subsidiaries SUPPLEMENTAL FINANCIAL INFORMATION NON-GAAP MEASURES (CONTINUED) (Unaudited) -- 8 of 15 -- Adjusted EBITDA (non-GAAP measure) Three months ended September 30, 2022 (dollars in millions) Safety and Industrial Transportation and Electronics Health Care Consumer Corporate and Unallocated Total Company Net sales $ 2,894 $ 2,239 $ 2,076 $ 1,409 $ 1 $ 8,619 Business segment operating income (loss) (measure of segment operating performance) $ 652 $ 474 $ 452 $ 299 $ 2,279 $ 4,156 Add/(subtract): Depreciation and amortization 137 99 151 37 26 450 Adjustments for special items: Net costs for significant litigation 21 — — — 246 267 Divestiture costs — — — — 6 6 Gain on business divestitures — — — — (2,724) (2,724) Divestiture-related restructuring actions — — — — 41 41 Russia exit charges — — — — 109 109 Total special items $ 21 — — — $ (2,322) (2,301) Adjusted EBITDA (non-GAAP measure) (c) $ 810 $ 573 $ 603 $ 336 $ (17) $ 2,305 Adjusted EBITDA margin (non-GAAP measure) (c) 28.0 % 25.7 % 29.1 % 23.8 % 26.7 % Adjusted EBITDA (non-GAAP measure) Three months ended September 30, 2021 (dollars in millions) Safety and Industrial Transportation and Electronics Health Care Consumer Corporate and Unallocated Total Company Net sales $ 3,005 $ 2,327 $ 2,173 $ 1,434 $ 3 $ 8,942 Business segment operating income (measure of segment operating performance) $ 562 $ 435 $ 510 $ 308 $ (27) $ 1,788 Add/(subtract): Depreciation and amortization 149 106 158 37 26 476 Adjustments for special items: Net costs for significant litigation 60 — — — 37 97 Adjusted EBITDA (non-GAAP measure) (c) $ 771 $ 541 $ 668 $ 345 $ 36 $ 2,361 Adjusted EBITDA margin (non-GAAP measure) (c) 25.7 % 23.3 % 30.7 % 24.1 % 26.4 % 3M Company and Subsidiaries SUPPLEMENTAL FINANCIAL INFORMATION NON-GAAP MEASURES (CONTINUED) (Unaudited) -- 9 of 15 -- Adjusted EBITDA (non-GAAP measure) Nine months ended September 30, 2022 (dollars in millions) Safety and Industrial Transportation and Electronics Health Care Consumer Corporate and Unallocated Total Company Net sales $ 8,869 $ 6,847 $ 6,379 $ 4,052 $ 3 $ 26,150 Business segment operating income (loss) (measure of segment operating performance) $ 581 $ 1,446 $ 1,394 $ 770 $ 1,716 $ 5,907 Add/(subtract): Depreciation and amortization 425 302 461 111 72 1,371 Adjustments for special items: Net costs for significant litigation 1,421 — — — 812 2,233 Divestiture costs — — — — 6 6 Gain on business divestitures — — — — (2,724) (2,724) Divestiture-related restructuring actions — — — — 41 41 Russia exit charges — — — — 109 109 Total special items 1,421 — — — (1,756) (335) Adjusted EBITDA (non-GAAP measure) (c) $ 2,427 $ 1,748 $ 1,855 $ 881 $ 32 $ 6,943 Adjusted EBITDA margin (non-GAAP measure) (c) 27.4 % 25.5 % 29.1 % 21.7 % 26.6 % Adjusted EBITDA (non-GAAP measure) Nine months ended September 30, 2021 (dollars in millions) Safety and Industrial Transportation and Electronics Health Care Consumer Corporate and Unallocated Total Company Net sales $ 9,133 $ 7,078 $ 6,407 $ 4,123 $ 2 $ 26,743 Business segment operating income (measure of segment operating performance) $ 1,976 $ 1,504 $ 1,522 $ 867 $ (116) $ 5,753 Add/(subtract): Depreciation and amortization 440 308 477 108 75 1,408 Adjustments for special items: Net costs for significant litigation 177 — — — 182 359 Adjusted EBITDA (non-GAAP measure) (c) $ 2,593 $ 1,812 $ 1,999 $ 975 $ 141 $ 7,520 Adjusted EBITDA margin (non-GAAP measure) (c) 28.4 % 25.6 % 31.2 % 23.7 % 28.1 % ______________________________________ (c) Adjusted EBITDA and adjusted EBITDA margin are not defined under U.S. GAAP. Therefore, adjusted EBITDA and adjusted EBITDA margin should not be considered a substitute for other measures prepared in accordance with U.S. GAAP and may not be comparable to similarly titled measures used by other companies. The Company defines adjusted EBITDA as net income attributable to 3M, adjusted for net income/(loss) attributable to noncontrolling interest, (income)/loss from unconsolidated subsidiaries, provision for income taxes, other expense/(income), depreciation and amortization expense, and special items. For business segments, the Company defines adjusted EBITDA as business segment operating income (loss) (3M’s measure of segment operating performance) adjusted for depreciation and amortization expense and special items. The Company defines adjusted EBITDA margin as adjusted EBITDA divided by net sales. Special items for the periods presented include the items described in the section entitled “Description of Special Items”. The Company considers these non-GAAP measures in evaluating and managing the Company’s operations. The Company believes adjusted EBITDA and adjusted EBITDA margin are meaningful to investors as they provide useful analyses of ongoing underlying operating trends. 3M Company and Subsidiaries SUPPLEMENTAL FINANCIAL INFORMATION NON-GAAP MEASURES (CONTINUED) (Unaudited) -- 10 of 15 -- Net Debt (non-GAAP measure) September 30, 2022 December 31, 2021 Total debt $ 15,705 $ 17,363 Less: Cash, cash equivalents and marketable securities 3,616 4,792 Net debt (d) $ 12,089 $ 12,571 ______________________________________ (d) Net debt is not defined under U.S. GAAP and may not be computed the same as similarly titled measures used by other companies. The Company defines net debt as total debt less the total of cash, cash equivalents and current and long-term marketable securities. 3M believes net debt is meaningful to investors as 3M considers net debt and its components to be an important indicator of liquidity and a guiding measure of capital structure strategy. Description of Special Items: In addition to reporting financial results in accordance with U.S. GAAP, the Company also provides various non-GAAP measures that incorporate adjustments for the impacts of special items. Special items incorporated in the preparation of these non-GAAP measures for the periods presented include the items described below: Net costs for significant litigation: • These relate to 3M's respirator mask/asbestos, PFAS-related other environmental, and Combat Arms Earplugs matters. Net costs include the impacts of changes in accrued liabilities, external legal fees, and insurance recoveries, along with the associated tax impacts. Prior to initiating voluntary chapter 11 bankruptcy proceedings in July 2022, net costs related to Combat Arms Earplugs and Aearo-respirator mask/asbestos matters along with non-Aearo respirator mask/ asbestos matters were reflected as special items in the Safety and Industrial business segment. During the bankruptcy period, net costs related to Combat Arms Earplugs and Aearo-respirator mask/asbestos matters are reflected as corporate special items in Corporate and Unallocated. In the third quarter of 2022 and 2021, 3M made payments of approximately $318 million and $105 million, respectively, related to net costs for significant litigation. In the first nine months of 2022 and 2021, 3M made payments of approximately $681 million and $258 million, respectively, related to net costs for significant litigation. Divestiture costs: • These include costs related to separating and divesting substantially an entire business segment of 3M following public announcement of its intended divestiture. In the third quarter and first nine months of 2022, 3M made payments of approximately $3 million associated with divestiture costs. Gain/loss on sale of businesses: • In the third quarter of 2022, 3M recorded a pre-tax gain of $2.7 billion ($2.7 billion after tax) related to the split-off and combination of its Food Safety business with Neogen Corporation. Divestiture-related restructuring actions: • In the third quarter of 2022, following the split-off of the Food Safety business, management approved and committed to undertake certain restructuring actions addressing corporate functional costs across 3M in relation to the magnitude of amounts previously allocated to the divested business. In the third quarter of 2022 and 2021, 3M made payments of approximately $4 million and $2 million, respectively, associated with divestiture-related restructuring actions. In the first nine months of 2022 and 2021, 3M made payments of approximately $5 million and $7 million, respectively, associated with divestiture-related restructuring actions. Russia exit charges: • In the third quarter of 2022, 3M recorded a charge primarily related to impairment of net assets in Russia in connection with management’s committed exit and disposal plan. In the third quarter and first nine months of 2022, 3M made payments of approximately $2 million, related to Russia exit charges. 3M Company and Subsidiaries SUPPLEMENTAL FINANCIAL INFORMATION NON-GAAP MEASURES (CONTINUED) (Unaudited) -- 11 of 15 -- Enactment/measurement period adjustments related to the Tax Cuts and Jobs Act (TCJA) • In the first nine months of 2022 and 2021, 3M made payments of approximately $68 million and $77 million, related to the transition tax expense incurred as a result of the 2017 enactment of the TCJA. 3M Company and Subsidiaries SUPPLEMENTAL FINANCIAL INFORMATION NON-GAAP MEASURES (CONTINUED) (Unaudited) -- 12 of 15 -- Three months ended September 30, 2022 Sales Change Analysis By Geographic Area Americas Asia Pacific Europe, Middle East and Africa Worldwide Organic sales 2.3 % 2.8 % (0.3) % 2.0 % Divestitures (0.7) (0.5) (0.2) (0.5) Translation (0.5) (8.3) (12.9) (5.1) Total sales change 1.1 % (6.0) % (13.4) % (3.6) % Nine months ended September 30, 2022 Sales Change Analysis By Geographic Area Americas Asia Pacific Europe, Middle East and Africa Worldwide Organic sales 2.8 % 1.3 % (1.4) % 1.6 % Divestitures (0.2) (0.2) (0.1) (0.2) Translation (0.2) (5.6) (9.5) (3.6) Total sales change 2.4 % (4.5) % (11.0) % (2.2) % Three months ended September 30, 2022 Worldwide Sales Change By Business Segment Organic sales Acquisitions Divestitures Translation Total sales change Safety and Industrial 1.7 % — % — % (5.4) % (3.7) % Transportation and Electronics 3.0 — (0.8) (6.0) (3.8) Health Care 1.7 — (1.3) (4.8) (4.4) Consumer 1.5 — — (3.2) (1.7) Total Company 2.0 — (0.5) (5.1) (3.6) Nine months ended September 30, 2022 Worldwide Sales Change By Business Segment Organic sales Acquisitions Divestitures Translation Total sales change Safety and Industrial 1.0 % — % — % (3.9) % (2.9) % Transportation and Electronics 1.1 — (0.3) (4.1) (3.3) Health Care 3.7 — (0.5) (3.6) (0.4) Consumer 0.8 — — (2.5) (1.7) Total Company 1.6 — (0.2) (3.6) (2.2) ______________________________________ (e) Total sales change is calculated based on reported sales results. The components of sales change include organic local- currency sales, acquisitions, divestitures, and translation. Organic local-currency sales include both organic volume impacts (which excludes acquisition and divestiture impacts) and selling price changes. Acquisition and divestiture impacts are measured separately for the first 12 months post-transaction. 3M Company and Subsidiaries SALES CHANGE ANALYSIS (e) (Unaudited) -- 13 of 15 -- 3M discloses business segment operating income as its measure of segment profit/loss, reconciled to both total 3M operating income and income before taxes. Business segment operating income excludes certain expenses and income that are not allocated to business segments (as described below in “Corporate and Unallocated”). Effective in the first quarter of 2022, the measure of segment operating performance used by 3M’s chief operating decision maker (CODM) changed and, as a result, 3M’s disclosed measure of segment profit/loss (business segment operating income) was updated. The change to business segment operating income aligns with the update to how the CODM assesses performance and allocates resources for the Company’s business segments. The changes included the items described below. The financial information presented herein reflects the impact of these business segment reporting changes for all periods presented. Eliminating inclusion of dual credit in measure of segment operating performance 3M business segment operating performance measures were updated to no longer include dual credit to business segments for certain sales and related operating income. Management previously evaluated its business segments based on net sales and operating income performance, including dual credit reporting. 3M reflected additional (“dual”) credit to another business segment when the customer account activity (“sales district”) with respect to the particular product sold to the external customer was provided by a different business segment. For example, privacy screen protection products are primarily sold by the Display Materials and Systems Division within the Transportation and Electronics business segment; however, certain sales districts within the Consumer business segment provide the customer account activity for sales of the product to particular customers. In this example, the non-primary selling segment (Consumer) previously would also have received credit for the associated net sales initiated through its sales district and the related approximate operating income. The offset to the dual credit business segment reporting was reflected as a reconciling item entitled “Elimination of Dual Credit,” such that sales and operating income in total were unchanged. Reflecting certain litigation-related costs in the Safety and Industrial segment's operating performance measure 3M's business segment operating performance measure with respect to its Safety and Industrial business segment was updated relative to litigation-related costs for non-Aearo and Aearo respirator respirator mask/asbestos litigation matters. Previously, 3M included these costs, when significant, as a special item within Corporate and Unallocated. 3M changed to include all litigation-related costs associated with respirator mask/asbestos litigation matters (along with other Safety and Industrial matters already included therein, such as those related to Combat Arms Earplugs) within the Safety and Industrial business segment. Note, however, that prospectively during the Aearo chapter 11 bankruptcy period (which began in July 2022) net costs for significant litigation associated with Combat Arms Earplugs and Aearo-respirator mask/ asbestos matters are reflected in Corporate and Unallocated. BUSINESS SEGMENT INFORMATION Three months ended September 30, Nine months ended September 30, NET SALES (Millions) 2022 2021 2022 2021 Safety and Industrial $ 2,894 $ 3,005 $ 8,869 $ 9,133 Transportation and Electronics 2,239 2,327 6,847 7,078 Health Care 2,076 2,173 6,379 6,407 Consumer 1,409 1,434 4,052 4,123 Corporate and Unallocated 1 3 3 2 Total Company $ 8,619 $ 8,942 $ 26,150 $ 26,743 3M Company and Subsidiaries BUSINESS SEGMENTS (Unaudited) -- 14 of 15 -- BUSINESS SEGMENT INFORMATION Three months ended September 30, Nine months ended September 30, OPERATING INCOME (LOSS) (Millions) 2022 2021 2022 2021 Safety and Industrial $ 652 $ 562 $ 581 $ 1,976 Transportation and Electronics 474 435 1,446 1,504 Health Care 452 510 1,394 1,522 Consumer 299 308 770 867 Total business segment operating income (loss) 1,877 1,815 4,191 5,869 Corporate and Unallocated Corporate special items: Net costs for significant litigation (246) (37) (812) (182) Divestiture costs (6) — (6) — Gain on business divestitures 2,724 — 2,724 — Divestiture-related restructuring actions (41) — (41) — Russia exit charges (109) — (109) — Total corporate special items 2,322 (37) 1,756 (182) Other corporate expense - net (43) 10 (40) 66 Total Corporate and Unallocated 2,279 (27) 1,716 (116) Total Company operating income 4,156 1,788 5,907 5,753 Other expense/(income), net 24 31 112 113 Income before income taxes $ 4,132 $ 1,757 $ 5,795 $ 5,640 Corporate and Unallocated Corporate and Unallocated operating income includes “corporate special items” and “other corporate expense-net”. Corporate special items include net costs for significant litigation associated with Combat Arms Earplugs and Aearo-respirator mask/ asbestos matters during the chapter 11 bankruptcy period (which began in July 2022) and with PFAS-related other environmental matters. Corporate special items also include divestiture costs, gain/loss on business divestitures, divestiture- related restructuring costs, and Russia exit costs. Divestiture costs include costs related to separating and divesting substantially an entire business segment of 3M following public announcement of its intended divestiture. Other corporate expense-net includes items such as net costs related to limited unallocated corporate staff and centrally managed material resource centers of expertise costs, corporate philanthropic activity, and other net costs that 3M may choose not to allocate directly to its business segments. Other corporate expense-net also includes costs and income from transition supply, manufacturing, and service arrangements with Neogen Corporation following the 2022 split-off of 3M's Food Safety business and with the acquirer of the former Drug Delivery business following its 2020 divestiture. Items classified as revenue from this activity are included in Corporate and Unallocated net sales. Because Corporate and Unallocated includes a variety of miscellaneous items, it is subject to fluctuation on a quarterly and annual basis. 3M Company and Subsidiaries BUSINESS SEGMENTS - (CONTINUED) (Unaudited) -- 15 of 15 --